BCMA and CD19 Targeted Fast Dual CAR-T for BCMA+ Refractory/Relapsed Multiple Myeloma
Condition: Multiple Myeloma Intervention: Biological: GC012F injection Sponsors: Shanghai Changzheng Hospital; Gracell Biotechnology Ltd. Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials